DCGI asks manufacturers to take steps to prevent black-marketing, overpricing of COVID-19 drugs

In order to prevent black-marketing and overpricing of COVID-19 drugs such as Remdesivir, India's drugs regulator DCGI has asked manufacturers to set up a helpline for patients and also put on their websites details of distributors and supply chain.

from IndiaTV India: Google News Feed https://ift.tt/38GpTxM